Treatment of proximal deep-vein thrombosis with the oral direct factor Xa inhibitor rivaroxaban (BAY 59-7939): The ODIXa-DVT (oral direct factor Xa inhibitor BAY 59-7939 in patients with acute symptomatic deep-vein thrombosis) study

Giancarlo Agnelli, Alexander Gallus, Samuel Goldhaber, Sylvia Haas, Menno Huisman, Russel Hull, Ajay Kakkar, Frank Misselwitz, Sebastian Schellong

    Research output: Contribution to journalArticlepeer-review

    338 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)180-187
    Number of pages8
    Issue number2
    Publication statusPublished - 2007

    Cite this